Teratogenic effects of gabapentin on neural tube and limb development in mice

Neurosciences

Volumn 13, Issue 3, 2008, Pages 321-323

  Afshar, Mohammad ^a   Golalipour, Mohammad J ^b  

^a BIRJAND UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^b GOLESTAN UNIVERSITY OF MEDICAL SCIENCES   (Iran)

Author keywords

[No Author keywords available]

Indexed keywords

GABAPENTIN;

ANALYSIS OF VARIANCE; ANIMAL EXPERIMENT; ARTICLE; BODY WEIGHT; CONTROLLED STUDY; FEMALE; FETUS MALFORMATION; LIMB MALFORMATION; MALE; MOUSE; NEURAL TUBE DEFECT; NONHUMAN; PREGNANCY; PRENATAL EXPOSURE; STATISTICAL SIGNIFICANCE; TERATOGENICITY; VERTEBRA MALFORMATION;

EID: 47749155996     PISSN: 13196138     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (5)

1. Briggs GG, Freeman R, Yaffi SJ, editors. Drug in Pregnancy and Lactation: A reference guide to fetal and neonatal risk. 5th ed. Baltimore (MD): Williams & Wilkins; 1998. p. 477-478.
2. Web.tampabay.rr.com [homepage on the Internet] Parke-Davis. Product Information. Neurotin. 1997; pp: 1-19 [updated 2001 October 27; 2007 August 5]. Available from http://web.tampabay.rr.com/lymecfs/nfaq.htm.
3. Montouris G. Gabapentin exposure in human pregnancy: results from the Gabapentin Pregnancy Registry. Epilepsy Behav 2003; 4: 310-317.
4. Bittigau P, Sifringer M, Ikonomidou C. Antiepileptic drugs and apoptosis in the developing brain. Ann N Y Acad Sci 2003; 993: 103-114.
5. Pippenger CE. Pharmacology of Neural Tube Defects. Epilepsia 2003; 44: 24-32.